Multiple myeloma treatment - should be continued or not?

Br J Haematol. 2022 Jul;198(2):223-224. doi: 10.1111/bjh.18212. Epub 2022 Apr 25.

Author

Affiliation

¹ Department of Hematology, Tokushima Prefecture Central Hospital, Tokushima, Japan.

PMID: 35468218
DOI: 10.1111/bjh.18212

No abstract available

Keywords: immunodeficiency; immunoglobulin; multiple myeloma.

MeSH terms

Humans
Multiple Myeloma* / drug therapy